Company logo

PAVM - PAVmed Inc.

NASDAQ -> Healthcare -> Medical Devices
New York, United States
Type: Equity

PAVM price evolution
PAVM
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Jan 2023
Current assets
Cash $26.41 $37.16 $49.28 $39.74
Short term investments
Net receivables $0.04 $0.04 $0.03 $0.02
Inventory
Total current assets $32.46 $43.13 $53.84 $43.93
Long term investments
Property, plant & equipment $6.48 $7.04 $7.43 $5.49
Goodwill & intangible assets $1.93 $2.44 $2.94 $3.44
Total noncurrent assets $9.56 $10.56 $11.45 $10.05
Total investments
Total assets $42.02 $53.68 $65.29 $53.98
Current liabilities
Accounts payable $2.17 $1.16 $1.26 $2.7
Deferred revenue
Short long term debt $46.56 $44.42 $45.56 $34.79
Total current liabilities $54.51 $50.78 $50.55 $41.2
Long term debt $3.34 $3.73 $3.94 $1.85
Total noncurrent liabilities $3.34 $3.73 $3.94 $1.85
Total debt $49.91 $48.15 $49.5 $36.64
Total liabilities $57.85 $54.51 $54.48 $63.66
Shareholders' equity
Retained earnings -$278.53 -$260.78 -$246.17 -$228.17
Other shareholder equity
Total shareholder equity -$43.26 -$31.51 -$22.06 -$9.68
(in millions $) 31 Jan 2023 31 Dec 2021 31 Dec 2020 31 Dec 2019
Current assets
Cash $39.74 $77.26 $17.26 $6.22
Short term investments
Net receivables $0.02 $0.2
Inventory
Total current assets $43.93 $82.64 $18.94 $6.55
Long term investments
Property, plant & equipment $5.49 $1.58
Goodwill & intangible assets $3.44 $2.03
Total noncurrent assets $10.05 $4.34 $0.84 $0.69
Total investments
Total assets $53.98 $86.98 $19.78 $7.24
Current liabilities
Accounts payable $2.7 $3.3 $2.97 $2.35
Deferred revenue
Short long term debt $34.79 $14.96 $8.14
Total current liabilities $41.2 $7.56 $20.25 $11.88
Long term debt $1.85
Total noncurrent liabilities $1.85
Total debt $36.64 $14.96 $8.14
Total liabilities $63.66 $7.56 $20.25 $11.88
Shareholders' equity
Retained earnings -$228.17 -$138.91 -$88.28 -$53.71
Other shareholder equity $0.17 $1.48
Total shareholder equity -$9.68 $61.67 $1.9 -$3.82
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Revenue
Total revenue $0.79 $0.17 $0.45 $0.11
Cost of revenue $1.78 $1.69 $1.35 $1.62
Gross Profit -$0.99 -$1.52 -$0.9 -$1.51
Operating activities
Research & development $3.16 $3.47 $4.44 $6.67
Selling, general & administrative $10.87 $10.99 $14.56 $15.82
Total operating expenses $14.54 $14.96 $19.5 $23
Operating income -$15.53 -$16.48 -$20.4 -$24.5
Income from continuing operations
EBIT -$17.51 -$14.31 -$17.75 -$20.24
Income tax expense
Interest expense $0.16 $0.23 $0.18 $0.22
Net income
Net income -$17.67 -$14.54 -$17.93 -$20.46
Income (for common shares) -$17.75 -$14.61 -$18 -$20.53
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Revenue
Total revenue $0.38 $0.5
Cost of revenue $3.61 $0.58
Gross Profit -$3.24 -$0.09
Operating activities
Research & development $25.55 $19.85 $10.96 $6.63
Selling, general & administrative $60.36 $34.46 $12.39 $7.66
Total operating expenses $87.69 $54.31 $23.35 $14.3
Operating income -$90.93 -$54.39 -$23.35 -$14.3
Income from continuing operations
EBIT -$87.71 -$50.35 -$34.22 -$16.42
Income tax expense
Interest expense $1.27 $0.05 $0.03
Net income
Net income -$88.98 -$50.35 -$34.28 -$16.46
Income (for common shares) -$89.26 -$50.63 -$34.56 -$16.73
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Net income -$17.67 -$14.54 -$17.93 -$20.46
Operating activities
Depreciation $0.84 $0.86 $0.81 $0.74
Business acquisitions & disposals
Stock-based compensation $2.25 $2.51 $4.42 $4.95
Total cash flows from operations -$11.09 -$12.79 -$16.29 -$16.82
Investing activities
Capital expenditures -$0.02 -$0.01 $0.97 -$0.3
Investments
Total cash flows from investing -$0.02 -$0.01 $0.97 -$0.3
Financing activities
Dividends paid
Sale and purchase of stock $0.08 $0.61 $0.74 $0.08
Net borrowings $0.07 $9.93
Total cash flows from financing $0.35 $0.68 $24.85 $0.08
Effect of exchange rate
Change in cash and equivalents -$10.76 -$12.12 $9.54 -$17.04
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net income -$88.98 -$50.35 -$34.28 -$16.46
Operating activities
Depreciation $2.55 $0.23 $0.02 $0.01
Business acquisitions & disposals -$3.2 -$2.25
Stock-based compensation $19.53 $15.01 $2.04 $1.57
Total cash flows from operations -$70.98 -$40.59 -$21.91 -$13.36
Investing activities
Capital expenditures -$1.54 -$1.47 -$0.06 -$0.03
Investments
Total cash flows from investing -$4.74 -$3.72 -$0.06 -$0.03
Financing activities
Dividends paid
Sale and purchase of stock $0.77 $49.79 $16.39 $5.55
Net borrowings $35.23 -$14.97 $16.7 $5.94
Total cash flows from financing $38.21 $104.31 $33.01 $11.38
Effect of exchange rate
Change in cash and equivalents -$37.51 $60 $11.04 -$2
Fundamentals
Market cap $256.16M
Enterprise value $279.66M
Shares outstanding 119.70M
Revenue $1.51M
EBITDA -$66.55M
EBIT -$69.81M
Net Income -$70.60M
Revenue Q/Q 940.79%
Revenue Y/Y 168.14%
P/E ratio -3.63
EV/Sales 184.59
EV/EBITDA -4.20
EV/EBIT -4.01
P/S ratio 169.08
P/B ratio -5.92
Book/Share -0.36
Cash/Share 0.22
EPS -$0.59
ROA -131.37%
ROE 265.14%
Debt/Equity -6.58
Net debt/EBITDA -0.47
Current ratio 0.60
Quick ratio 0.60